Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: A randomized controlled trial

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 4, 2012, Pages 489-495

  Badawy, Ahmed M ^a   Elnashar, Aboubakr M ^b   Mosbah, Alaa A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b BENHA UNIVERSITY   (Egypt)

Author keywords

Adenomyosis; gonadotropin releasing hormone agonists; letrozole

Indexed keywords

GOSERELIN; LETROZOLE;

ADENOMYOSIS; ADULT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DYSMENORRHEA; DYSPAREUNIA; FEMALE; FEMALE SUBFERTILITY; HUMAN; MENORRHAGIA; METRORRHAGIA; ORGAN SIZE; OUTCOME ASSESSMENT; PELVIS PAIN SYNDROME; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; UTERUS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AROMATASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIOSIS; FEMALE; FERTILITY PRESERVATION; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; INJECTIONS, SUBCUTANEOUS; NITRILES; PREMENOPAUSE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TRIAZOLES; UTERINE DISEASES; YOUNG ADULT;

EID: 84858770658     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01350.x     Document Type: Review

References (23)

1. Farquhar C, Brosens I,. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006; 20: 603-16. (Pubitemid 44688625)
2. Kitawaki J,. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol. 2006; 20: 493-502. (Pubitemid 44688624)
3. Wang P, Su W, Sheu B, Liu W,. Adenomyosis and its variance: Adenomyoma and female fertility. Taiwan J Obstet Gynecol. 2009; 48: 232-8.
4. Wood C,. Adenomyosis: difficult to diagnose, and difficult to treat. Diagn Ther Endosc. 2001; 7: 89-95. (Pubitemid 33672278)
5. Parsanezhad M, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt E,. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril. 2010; 93: 192-8.
6. Kimura F, Takahashi K, Takebayashi K, Fujiwara M, Kita N, Noda Y, Harada N,. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist. Fertil Steril. 2007; 87: 1468-73.
7. Igarashi M, Abe Y, Fukuda M, Ando A, Miyasaka M, Yoshida M,. Nobel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril. 2000; 74: 412-3. (Pubitemid 30604216)
8. Grow DR, Filer RB,. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol. 1991; 78: 538-9.
9. Nelson JR, Corson SL,. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril. 1993; 59: 441-3. (Pubitemid 23057803)
10. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T,. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissue but not in normal endometrium. Biol Reprod. 1997; 57: 514-9. (Pubitemid 27349909)
11. Noble L, Simpson E, Johns A, Bulun S,. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996; 81: 736-43.
12. Fedele L, Bianchi S, Dorta M,. Transvaginal ultrasonography for differential diagnosis of adenomyosis versus leiomyoma. Am J Obstet Gynecol. 1992; 167: 603-6.
13. Ishihara H, Kitawaki J, Kado N, Koshiba H, Fushiki S, Honjo H,. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril. 2003; 79: 735-42. (Pubitemid 36279678)
14. Takayama K, Zeitoun K, Gunby R, Sasano H, Carr B, Bulun S,. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998; 69: 709-13. (Pubitemid 28188468)
15. Kang JL, Wang XX, Nie ML, Huang XH,. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Gynecol Obstet Invest. 2009; 69: 73-7.
16. Iveson T, Smith I, Ahern J, Smithers D, Trunet P, Dowsett M,. Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer. Cancer Res. 1993; 53: 266-270. (Pubitemid 23031835)
17. Shozu M, Murakami K, Segawa T, Kasai T, Inoue M,. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertile Steril 2003; 79: 628-31. (Pubitemid 36293465)
18. Badawy A, Shokeir T, Allam A, Abdelhady H,. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand. 2009; 88: 187-91.
19. Harding S, Pesce A, McMillan L,. Symptomatic ascites complicating GnRH analogue use for myoma shrinkage. Br J Obstet Gynaecol 1993; 100: 1054-6. (Pubitemid 23344181)
20. Friedman A,. Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri. Fertil Steril. 1993; 59: 677-8. (Pubitemid 23086334)
21. Hansen L, Batzer F, Corson S, Bello S,. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens. J Reprod Med. 1997; 42: 247-50. (Pubitemid 27187845)
22. Lepine A, Hillis S, Marchbanks P, Koonin L, Morrow B, Kieke B, et al,. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ. 1997; 46: 1-15.
23. Ferrero S, David J Gillott, Pier L Venturini, Valentino R,. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol. 2011; 9: 89-93.